Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection

NDTV Profit 2022-12-27

Views 5

#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.
CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive

Share This Video


Download

  
Report form